Bionano Genomics, Inc. (BNGO) Financials

BNGO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 181.9 million 62.9 million
2023-06-30 271.4 million 56.6 million
2023-03-31 292.2 million 60.7 million
2022-12-31 307.5 million 58.1 million

BNGO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -26.4 million 4.0 million
2023-06-30 -37.2 million 3.9 million
2023-03-31 -32.8 million 3.9 million
2022-12-31 -36.1 million 5.5 million

BNGO Net Income

No data available :(

BNGO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 63.6 million - 10.1 million
2023-06-30 77.1 million - 10.7 million
2023-03-31 95.8 million - 11.2 million
2022-12-31 113.2 million - 11.7 million

BNGO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 35.0 million
2023-06-30 31.5 million
2023-03-31 30.2 million
2022-12-31 29.7 million

BNGO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 75000 13.8 million 24.9 million -
2023-06-30 511000 14.6 million 26.9 million -
2023-03-31 360000 13.9 million 26.0 million -
2022-12-31 1.6 million 14.0 million 25.3 million -

BNGO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 9.3 million 6.6 million
2023-06-30 8.7 million 6.4 million
2023-03-31 7.4 million 5.3 million
2022-12-31 8.2 million 6.4 million

BNGO

Price: $0.86

52 week price:
0.75
11.80

Earnings Per Share: -6.81 USD

P/E Ratio: -0.16

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 6.9 million

Market Capitalization: 55.8 million

Links: